691. Activity of TNP-2092 Against Biofilms Formed by Prosthetic Joint Infection-Associated Staphylococci

BACKGROUND: Infection occurs in ~1–2% of prosthetic joint replacement surgeries, with staphylococci being the most common cause. TNP-2092 is an investigational drug composed of rifamycin and quinolizinone pharmacophores conjugated via a stable linker. Here, we determined TNP-2092’s in vitro activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Cody, Schmidt-Malan, Suzannah, Yuan, Ying, He, Shijie, Ma, Zhenkun, Patel, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810892/
http://dx.doi.org/10.1093/ofid/ofz360.759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810892/
http://dx.doi.org/10.1093/ofid/ofz360.759

Ejemplares similares